These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9380912)

  • 21. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
    Lim LS; Hoeksema LJ; Sherin K;
    Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward targeted hypertension screening guidelines.
    van Buuren S; Boshuizen HC; Reijneveld SA
    Med Decis Making; 2006; 26(2):145-53. PubMed ID: 16525168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health surveillance for hereditary hemochromatosis.
    Wetterhall SF; Cogswell ME; Kowdley KV
    Ann Intern Med; 1998 Dec; 129(11):980-6. PubMed ID: 9867751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 33. A reader's guide to economic analysis in the GI literature.
    Provenzale D; Lipscomb J
    Am J Gastroenterol; 1996 Dec; 91(12):2461-70. PubMed ID: 8946967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis.
    Buffone GJ; Beck JR
    Clin Chem; 1994 Aug; 40(8):1631-6. PubMed ID: 8045021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening in primary health care. Presentation of a case of familial hemochromatosis].
    Ibáñez Estella JA; Sánchez Ibáñez A; Rubio Montañés ML; Malumbres Juarros P; Izquierdo Clemente C
    An Med Interna; 1992 Oct; 9(10):516. PubMed ID: 1420767
    [No Abstract]   [Full Text] [Related]  

  • 36. Upstream like a salmon (early diagnosis of hemochromatosis).
    Barlow JF
    S D J Med; 1997 Jan; 50(1):7. PubMed ID: 9029987
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemochromatosis.
    Wkly Epidemiol Rec; 1996 Nov; 71(46):349-50. PubMed ID: 8961811
    [No Abstract]   [Full Text] [Related]  

  • 38. Statistical analysis of population screening.
    Alexander FE
    Med Lab Sci; 1989 Jul; 46(3):255-67. PubMed ID: 2691801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicians dumping iron.
    Lindenmayer JM
    Med Health R I; 1997 Aug; 80(8):266-7. PubMed ID: 9283184
    [No Abstract]   [Full Text] [Related]  

  • 40. Haemochromatosis and type 2 diabetes.
    Aldersley MA; Allgar V; Howdle PD; Markham AF
    Lancet; 1998 Sep; 352(9133):1067-8. PubMed ID: 9759782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.